Valuation: PolyPeptide Group AG

Capitalization 1.31B 1.51B 1.2B 1.13B 2.11B 144B 2.14B 14.28B 5.56B 69.68B 5.68B 5.55B 242B P/E ratio 2026 *
78.6x
P/E ratio 2027 * 33.8x
Enterprise value 1.42B 1.63B 1.3B 1.22B 2.28B 156B 2.31B 15.44B 6.01B 75.34B 6.14B 6B 262B EV / Sales 2026 *
2.95x
EV / Sales 2027 * 2.63x
Free-Float
39.12%
Yield 2026 *
-
Yield 2027 * 0.07%
1 day-3.45%
1 week-3.96%
Current month-3.96%
1 month-10.67%
3 months+53.26%
6 months+47.07%
Current year+39.46%
1 week 36.15
Extreme 36.15
38.95
1 month 36.15
Extreme 36.15
40.4
Current year 23.1
Extreme 23.1
41.7
1 year 19.62
Extreme 19.62
41.7
3 years 13.22
Extreme 13.22
41.7
5 years 13.22
Extreme 13.22
147.4
10 years 13.22
Extreme 13.22
147.4
Manager TitleAgeSince
Chief Executive Officer 54 11/04/2023
Director of Finance/CFO 54 01/01/2024
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Director/Board Member 73 31/12/2005
Chairman 69 31/03/2021
Director/Board Member 62 31/12/2020
Date Insider Type Main position Quantity % Market Cap.
12/11/23Buy 2,500 0.0075%
11/10/23Buy 159,959 0.4829%
05/04/23Buy 45,842 0.1384%
Change 5d. change 1-year change 3-years change Capi.($)
-3.45%-3.96%+70.09%+51.67% 1.51B
+0.55%+2.39%+46.96%+159.28% 1,009B
+2.02%+3.30%+50.15%+46.84% 560B
+1.02%+4.37%+19.70%+66.47% 401B
+0.77%-0.67%+21.96%+13.64% 328B
+0.44%+1.74%+52.96%+11.21% 298B
+2.24%+0.41%+28.53%+17.90% 288B
+1.85%+0.14%+21.53%+31.82% 272B
+4.43%-3.11%-42.11%-48.01% 194B
+1.15%+3.80%+20.41%+58.00% 189B
Average +1.10%+1.19%+29.02%+40.88% 354.11B
Weighted average by Cap. +1.33%+2.19%+32.82%+66.91%

Financials

2026 *2027 *
Net sales 480M 554M 441M 414M 772M 52.83B 784M 5.24B 2.04B 25.55B 2.08B 2.04B 88.85B 550M 635M 505M 475M 884M 60.52B 898M 6B 2.33B 29.27B 2.38B 2.33B 102B
Net income 16.51M 19.07M 15.15M 14.26M 26.55M 1.82B 26.97M 180M 70.09M 879M 71.6M 70.04M 3.06B 41.1M 47.46M 37.71M 35.48M 66.08M 4.52B 67.12M 448M 174M 2.19B 178M 174M 7.61B
Net Debt 106M 123M 97.52M 91.75M 171M 11.7B 174M 1.16B 451M 5.66B 461M 451M 19.67B 137M 158M 126M 118M 220M 15.07B 224M 1.49B 581M 7.29B 594M 581M 25.34B
Logo PolyPeptide Group AG
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Employees
1,440
Date Price Change Volume
05/06/26 36.40 CHF -3.45% 52,676
04/06/26 37.70 CHF +1.34% 66,977
03/06/26 37.20 CHF -2.87% 33,389
02/06/26 38.30 CHF +1.19% 26,336
01/06/26 37.85 CHF -0.13% 54,284
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
39.67EUR
Average target price
39.11EUR
Spread / Average Target
-1.42%

Quarterly revenue - Rate of surprise